Home
About
Overview
Sharing Data
ORCID
Help
History (5)
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
Cytokine therapy in metastatic renal cancer.
Diaries
PrP 27-30 Protein
Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cytokine therapy in metastatic renal cancer.
Cytokine therapy in metastatic renal cancer. N Engl J Med. 1998 Sep 17; 339(12):849; author reply 850-1.
View in:
PubMed
subject areas
Carcinoma, Renal Cell
Disease Progression
Humans
Interferon-gamma
Kidney Neoplasms
Recombinant Proteins
Remission, Spontaneous